Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability


KURT M., ÖZTAŞ E., KURAN S. , ÖNAL İ., KEKİLLİ M., HAZNEDAROĞLU İ.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.27, no.5, 2009 (Journal Indexed in SCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 5
  • Publication Date: 2009
  • Doi Number: 10.1016/j.ajem.2008.09.003
  • Title of Journal : AMERICAN JOURNAL OF EMERGENCY MEDICINE

Abstract

Ankaferd Blood Stopper (ABS) (Ankaferd Health Products Ltd., Istanbul, Turkey) is a standardized unique combined medicinal plant extract, which has been approved in the management of postsurgery dental bleeding and external hemorrhage in Turkey [1]. ABS induces a very rapid formation (<1 second) of a specific hemostatic protein network within vital erythroid aggregation in the injured vascular area [1]. The data on the efficacy of ABS in gastrointestinal (GI) system bleeding is limited to case reports only [2-4]. Here, we present a patient with a severe GI mucosal bleeding and nasal hemorrhage leading to hemodynamic instability, which was successfully controlled via the topical application of high-dose ABS.